Akèy › Kansè nan tete › Arizona › Scottsdale
Etid klinik pou Kansè nan tete nan Scottsdale, AZ
18 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Scottsdale (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Ap rekriteFaz 2
- Mayo Clinic, Scottsdale
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
Ap rekriteFaz 3
- Mayo Clinic, Scottsdale
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Ap rekriteFaz 3
- Ironwood Cancer & Research Centers, Scottsdale
Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer
Ap rekriteFaz 2
- Mayo Clinic in Arizona, Scottsdale
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Ap rekrite
- Honor Health Research Institute, Scottsdale
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Ap rekriteFaz 3
- Mayo Clinic, Scottsdale
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Ap rekriteFaz 1
- Mayo Clinic of Scottsdale, Scottsdale
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Ap rekriteFaz 1
- HonorHealth, Scottsdale
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
Ap rekriteFaz 2
- Mayo Clinic in Arizona, Scottsdale
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Ap rekriteFaz 1
- HonorHealth Research Institute, Scottsdale
Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer
Ap rekriteFaz 2
- Mayo Clinic in Arizona, Scottsdale
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Ap rekriteFaz 3
- Mayo Clinic - Scottsdale, Scottsdale
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Ap rekriteFaz 2
- Mayo Clinic - Scottsdale, Scottsdale
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Ap rekriteFaz 3
- Ironwood Cancer & Research Centers, Scottsdale
Cancer Genetic Testing in Ethnic Populations
Ap rekrite
- Mayo Clinic in Arizona, Scottsdale
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Ap rekriteFaz 1
- HonorHealth Research Institute, Scottsdale
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Ap rekriteFaz 4
- Scottsdale Medical Imaging, LLC, Scottsdale
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Scottsdale
Etid Kansè nan tete nan lòt vil
- New York City, NY136 etid
- Houston, TX126 etid
- Boston, MA112 etid
- Nashville, TN81 etid
- Los Angeles, CA73 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Queens, NY64 etid
- Durham, NC64 etid
- Chicago, IL59 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Scottsdale
- Kansè (tout kalite)18 etid
- Kansè Metastatik17 etid
- Kansè pwostat17 etid
- Kansè kolorektal16 etid
- Kansè Poumon ki pa ti selil15 etid
- Kansè pankreyas13 etid
- Melanom10 etid
- Kolit Ulseratif8 etid
- Kansè poumon8 etid
- Kansè fwa (Kasinòm epatoselilè)7 etid
- Maladi Alzheimer7 etid
- Kansè tete negatif triple7 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.